PCSK9 inhibitors are advanced drugs for heart disease that cost $5,850 per year. They use a different mechanism than statins.
While this FDA approval for primary prevention doesn't guarantee insurance coverage, it's one more step in that direction.
While this FDA approval for primary prevention doesn't guarantee insurance coverage, it's one more step in that direction.
High blood pressure slowly damages the cardiac walls, leading to less blood flow, which impairs kidney function, which leads to less effective filtration of sodium and potassium, leading to higher blood pressure. So in this way, heart failure becomes self-reinforcing.
One way to break that feedback loop is to start a high-potassium diet.